Immunofluorescence Studies of Lung Tissue in Cystic Fibrosis

References

• Wood RE, Boat TF, Doershuk CF. Cystic fibrosis. Am Rev Respir Dis 1976; 113: 833–78
   PubMed Web of Science ®Google Scholar
• Høiby N. Microbiology of lung infections in cystic fibrosis patients. Acta Paediatr Scand Suppl 1982; 301: 33–54
   Google Scholar
• Pedersen SS, Høiby N., Shand GH, Pressler T. Antibody response toPseudomonas deruginosaantigens in cystic Fibrosis. Antibiot Chemother 1989; 42: 130–53
   PubMedGoogle Scholar
• Schiøtz PO, Høiby N, Juhl F, Permin H, Nielsen H., Svehag SE. Immune complexes in cystic fibrosis. Acta Pathol Microbiol Scand (Sect C) 1977; 85: 57–64
   PubMedGoogle Scholar
• Berdischewsky M, Pollack M, Young LS, Chia D, Osher AB, Barnett EV. Circulating immune complexes in cystic fibrosis. Pediatr Res 1980; 14: 830–3
   PubMedGoogle Scholar
• Schiøtz PO, Nielsen H, Høiby N, Glikmann G, Svehag SE. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronicPseudomonas aeruginosalung infection. Acta Pathol Microbiol Scand (Sect C) 1978; 86: 37–40
   PubMedGoogle Scholar
• Church JA, Jordan SC, Keens TG, Wang CI. Circulating immune complexes in patients with cystic fibrosis. Chest 1981; 80: 405–11
   PubMedGoogle Scholar
• Moss RB, Hsu YP, Lewiston NJ, et al. Association of systemic immune complexes, complement activation, and antibodies toPseudomonas aeruginosalipopolysaccharide and exotoxin A with mortality in cystic fibrosis. Am Rev Respir Dis 1986; 133: 648–65
   PubMedGoogle Scholar
• Wisnieski JJ., Todd EW, Fuller RK, et al. Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway. Am Rev Respir Dis 1985; 132: 770–6
   PubMedGoogle Scholar
• Høiby N, Schiøtz PO. Immune complex mediated tissue damage in the lungs of cystic fibrosis patients with chronicPseudomonas aeruginosainfection. Acta Paediatr Scand Suppl 1982; 301: 63–73
   Google Scholar
• Doring G, Albus A, Høiby N. Immunologic aspects of cystic fibrosis. Chest 1988; 94(Suppl)109
   Google Scholar
• McFarlane H., Holzel A., Brenchley P, et al. Immune complexes in cystic fibrosis. Br Med J 1975; 1: 423–28
   PubMedGoogle Scholar
• Martinez-Tello FJ, Braun DG, Blanc WA. Immunoglobulin production in bronchial mucosa and bronchial lymph noes particularly in cystic fibrosis of the pancreas. J Immunol 1968; 101: 989–1003
   PubMed Web of Science ®Google Scholar
• Speert DP, Dimmick JE., Pier GB, Saunders JM, Hancock RE, Kelly N. An immunohistological evaluation ofPseudomonas aeruginosapulmonary infection in two patients with cystic fibrosis. Pediatr Res 1987; 22: 743–7
   PubMedGoogle Scholar
• Warnke RA, Bindl J., Doggett R. Methods for decreasing interstitial immunoglobulin in tissue slices and cryostat sections. Histochemical J 1983; 15: 637–44
   PubMedGoogle Scholar
• Matthews WJ, Jr, Williams M, Oliphint B, Geha R, Cohen HR. Hypogammaglobulinemia in patients with cystic fibrosis. N Engl J Med 1980; 302: 245–9
   PubMedGoogle Scholar
• Auerbach HS, Williams M, Kirkpatrick JA, Colten HR. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985; 2: 686–8
   PubMed Web of Science ®Google Scholar
• Fick RB, Jr, Stillwell PC. Controversies in the management of pulmonary disease due to cystic fibrosis. Chest 1989; 95: 1319–27
   PubMedGoogle Scholar
• Høiby N, Doring G., Schiøtz PO. Pathogenic mechanisms of chronicPseudomonas aeruginosainfections in cystic fibrosis patients. Antibiot Chemother 1987; 39: 60–76
   PubMedGoogle Scholar
• Moss RB, Hsu YP. Isolation and characterization of circulating immune complexes in cystic fibrosis. Clin Exp Immunol 1982; 47: 301–8
   PubMedGoogle Scholar
• Moss RB, Lewiston NJ. Immune complexes and humoral response toPseudomonas aeruginosain cystic fibrosis. Am Rev Respir Dis 1980; 121: 23–9
   PubMedGoogle Scholar
• Doring G, Buhl V, Høiby N, Schiøtz PO, Botzenhart K. Detection of proteases ofPseudomonas aeruginosain immune complexes isolated from sputum of cystic fibrosis patients. Acta Pathol Microbiol Immunol Scand (Sect C) 1984; 92: 307–12
   PubMedGoogle Scholar
• Abramowsky CR, Swinehart GL. The nephropathy of cystic fibrosis: A human model of chronic nephrotoxicity. Hum Pathol 1982; 13: 934–9
   PubMedGoogle Scholar
• Baltimore RS, Christie CD, Smith GJ. Immunohistopathologic localization ofPseudomonas aeruginosain lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 1989; 140: 1650–61
   PubMed Web of Science ®Google Scholar
• Disis ML, McDonald TL, Colombo JL, Kobayashi RH, Angle CR, Murray S. Circulating immune complexes in cystic fibrosis and their correlation to clinical parameters. Pediatr Res 1986; 20: 385–90
   PubMedGoogle Scholar
• Manthei U, Taussig LM, Beckerman RL, Strunk RC. Circulating immune complexes in cystic fibrosis. Am Rev Respir Dis 1982; 126: 253–7
   PubMedGoogle Scholar
• Davis CA, Abramowsky CR, Swinehart G. Circulating immune complexes and the nephropathy of cystic fibrosis. Hum Pathol 1984; 15: 244–7
   PubMedGoogle Scholar
• Tomashefski JF, Jr, Konstan MW, Bruce MC, Abramowsky CR. The pathologic characteristics of interstitial pneumonia in cystic fibrosis.A retrospective autopsy study. Am J Clin Pathol 1989; 91: 522–30
   PubMedGoogle Scholar
• Hodson ME, Turner-Warwick M. Autoantibodies in cystic fibrosis. Clin Allergy 1981; 11: 565–70
   PubMedGoogle Scholar
• Wallwork JC, Brenchley P, McCarthy J, et al. Some aspects of immunity in patients with cystic fibrosis. Clin Exp Immunol 1974; 18: 303–20
   PubMedGoogle Scholar
• Hodson ME, Turner-Warwick M. Autoantibodies in patients with chronic bronchitis. Br J Dis Chest 1976; 70: 83–8
   PubMedGoogle Scholar
• Hodson ME, Turner-Warwick M. Autoantibodies in patients with bronchial carcinoma. Thorax 1975; 30: 367–70
   PubMedGoogle Scholar